theory clinical_2_10
imports Main

begin

typedecl entity
typedecl event

consts
  SyntheticLethality :: "entity ⇒ bool"
  CoOccurrence :: "entity ⇒ bool"
  GeneticEvents :: "entity ⇒ bool"
  LossOfBRCA2 :: "entity ⇒ bool"
  CellDeath :: "entity ⇒ bool"
  Occurs :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Result :: "event ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Inability :: "event ⇒ bool"
  Repair :: "event ⇒ bool"
  DNADamage :: "entity"
  Through :: "event ⇒ entity ⇒ bool"
  MultiplePathways :: "entity"
  PARPInhibitors :: "entity ⇒ bool"
  DoubleStrandBreaks :: "entity ⇒ bool"
  SingleStrandBreakRepair :: "entity ⇒ bool"
  Cells :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Prevent :: "event ⇒ bool"
  Force :: "event ⇒ bool"
  Rely :: "event ⇒ bool"
  On :: "event ⇒ entity ⇒ bool"
  DefectiveHomologousRecombinationRepair :: "entity"
  ErrorProneNonHomologousEndJoining :: "entity"
  DNA :: "entity"
  BRCA2Loss :: "entity ⇒ bool"
  CumulativeDNADamage :: "entity ⇒ bool"
  SingularMechanism :: "entity"
  PrimaryRepairPathways :: "entity ⇒ bool"
  Compromised :: "entity ⇒ bool"
  Lead :: "event ⇒ bool"
  IncreasedReliance :: "event ⇒ bool"
  AlternativeRepairMechanisms :: "entity"
  Patients :: "entity ⇒ bool"
  PARP1Inhibition :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"

(* Explanation 1: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of BRCA2, results in cell death due to the inability to repair DNA damage through multiple pathways. *)
axiomatization where
  explanation_1: "∃x y z e1 e2 e3. SyntheticLethality x ∧ CoOccurrence y ∧ GeneticEvents y ∧ LossOfBRCA2 y ∧ CellDeath z ∧ Occurs e1 ∧ Agent e1 x ∧ Result e2 ∧ Agent e2 y ∧ Patient e2 z ∧ Inability e3 ∧ Repair e3 ∧ Patient e3 DNADamage ∧ Through e3 MultiplePathways"

(* Explanation 2: PARP inhibitors cause replication-associated double strand breaks by preventing single strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2 e3 e4. PARPInhibitors x ∧ DoubleStrandBreaks y ∧ SingleStrandBreakRepair z ∧ Cells w ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Force e3 ∧ Agent e3 x ∧ Patient e3 w ∧ Rely e4 ∧ Agent e4 w ∧ On e4 DefectiveHomologousRecombinationRepair ∧ On e4 ErrorProneNonHomologousEndJoining ∧ Repair e4 ∧ Patient e4 DNA"

(* Explanation 3: In the context of BRCA2 loss, synthetic lethality causes cells to rely on a singular mechanism to repair cumulative DNA damage, as the primary repair pathways are compromised, leading to an increased reliance on alternative repair mechanisms. *)
axiomatization where
  explanation_3: "∃x y z w e1 e2 e3 e4. BRCA2Loss x ∧ SyntheticLethality y ∧ Cells z ∧ CumulativeDNADamage w ∧ Cause e1 ∧ Agent e1 y ∧ Patient e1 z ∧ Rely e2 ∧ Agent e2 z ∧ On e2 SingularMechanism ∧ Repair e2 ∧ Patient e2 w ∧ PrimaryRepairPathways v ∧ Compromised v ∧ Lead e3 ∧ Agent e3 v ∧ IncreasedReliance e4 ∧ On e4 AlternativeRepairMechanisms"

theorem hypothesis:
  assumes asm: "Patients x ∧ LossOfBRCA2 x ∧ PARP1Inhibition y ∧ SyntheticLethality z"
  (* Hypothesis: Patients with loss of BRCA2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA *)
  shows "∃x y z e1 e2 e3. Patients x ∧ LossOfBRCA2 x ∧ PARP1Inhibition y ∧ SyntheticLethality z ∧ Benefit e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Cause e2 ∧ Agent e2 z ∧ Patient e2 x ∧ Rely e3 ∧ Agent e3 x ∧ On e3 SingularMechanism ∧ Repair e3 ∧ Patient e3 CumulativeDNADamage"
  sledgehammer
  oops

end
